Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.

Taylor, Sean C; Hurst, Beth; Martiszus, Ian; Hausman, Marvin S; Sarwat, Samar; Schapiro, Jeffrey M; Rowell, Sarah; Lituev, Alexander

Taylor, Sean C; Hurst, Beth; Martiszus, Ian; Hausman, Marvin S; Sarwat, Samar; Schapiro, Jeffrey M; Rowell, Sarah; Lituev, Alexander.

Afiliação

Taylor SC; GENSCRIPT USA INC., 860 Centennial Ave., Piscataway, NJ 08854, USA. Electronic address: sean.taylor@genscript.com.
Hurst B; Cayman Chemical, 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA.
Martiszus I; Cure-Hub, 12655 SW Beaverdam Rd., Beaverton, OR 97005, USA.
Hausman MS; FourthWall Testing LLC, 455 9th Street Suite 128, Winter Garden, FL 34787, USA.
Sarwat S; DYNEX Technologies, 14340 Sullyfield Circle, Chantilly, VA 20151-1621, USA.
Schapiro JM; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.
Rowell S; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.
Lituev A; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.

Vaccine ; 39(39): 5688-5698, 2021 09 15.

Article em En | MEDLINE | ID: mdl-34426026

Assuntos

Anticorpos Neutralizantes; COVID-19; Anticorpos Antivirais; Humanos; Imunidade; Testes de Neutralização; SARS-CoV-2; Estudos Soroepidemiológicos; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google